What the Lawsuits Allege
The Tylenol autism lawsuits were brought by parents, mostly mothers, who took acetaminophen, the active ingredient in Tylenol, during pregnancy and whose children were later diagnosed with autism spectrum disorder or ADHD. They allege the manufacturers and retailers should have warned that prenatal use could increase the risk of these conditions. The cases were consolidated as MDL 3043 in the Southern District of New York. It is a multidistrict litigation, not a class action.
It is important to be clear about the state of the science, because it is genuinely disputed. Some studies have reported an association between prenatal acetaminophen exposure and these conditions, while others have not. Notably, a large 2024 sibling-comparison study found no causal link. An association in some studies is not the same as proof that the drug causes autism.
Why the Federal Cases Were Dismissed
This litigation took an unusual turn. To win, plaintiffs had to show through expert testimony that acetaminophen can cause autism or ADHD. The judge held hearings on the reliability of that expert evidence and excluded the plaintiffs causation experts, finding their opinions did not meet the legal standard for scientific reliability. Without admissible causation experts, the court granted judgment for the defendants and effectively dismissed the federal cases.
The defendants, including the company that now makes Tylenol, have argued throughout that a causal relationship has not been established and that the expert evidence was unreliable. The dismissal was a ruling about the admissibility and sufficiency of evidence, not a declaration about every possible future study.
The Appeal and the Current Picture
The plaintiffs appealed to a federal appeals court, which heard arguments and, as of this update, had not issued a decision. If the dismissal is reversed, the federal litigation could resume and move toward trials. If it is upheld, the federal cases would effectively end, leaving only state-court lawsuits, which apply different evidentiary rules.
The subject also became politically charged in 2025, when federal officials publicly suggested a possible link and the FDA moved to note a possible association, while stopping short of confirming that acetaminophen causes autism. That remains contested, and major medical questions are unresolved. For anyone affected, the honest summary is that the federal case is in limbo, the science is disputed, and whether a viable claim exists depends heavily on how the appeal and state courts rule.
How to Get Legal Help
This litigation is unusual because the federal cases were dismissed and the science is genuinely contested, so whether any viable claim exists is far from certain and depends on a pending appeal and on state-court rules. Anyone considering a claim should speak with an attorney for a realistic assessment rather than assume a case exists, and treat any promise of a specific outcome with caution.
To follow the appeal and any further rulings, bookmark this page and subscribe to LawsuitWatch alerts.
Free Legal Evaluation
Do You Qualify to File a Claim?
Our network of verified plaintiff attorneys offers free, no-obligation case evaluations. Contingency fee representation means you pay nothing unless you win.
Tylenol Autism Lawsuit: Dismissed, Appealed, and Disputed: Frequently Asked Questions
Answers to the most common questions about this case and your legal options.
What is the Tylenol autism lawsuit about?
Parents who took acetaminophen during pregnancy and whose children were diagnosed with autism or ADHD allege manufacturers and retailers should have warned of a possible risk. The cases were consolidated as MDL 3043 in New York. It is an MDL, not a class action.
Was the Tylenol autism lawsuit dismissed?
The federal MDL was effectively dismissed after the court excluded the plaintiffs causation experts as not meeting the standard for scientific reliability and then granted judgment for the defendants. That dismissal is on appeal.
Does Tylenol cause autism?
That is not established. Some studies report an association between prenatal acetaminophen exposure and autism or ADHD, while others, including a large 2024 sibling-comparison study, found no causal link. Courts excluded the plaintiffs causation experts, and the FDA has noted only a possible association, not confirmed causation.
What happens next?
A federal appeals court is considering whether the dismissal should stand. If reversed, the federal litigation could resume; if upheld, only state-court cases, which use different rules, would remain. As of this update no decision had issued.
Should I file a Tylenol autism claim?
Because the federal cases were dismissed and the science is genuinely disputed, whether a viable claim exists is uncertain and depends on the appeal and state-court rules. Speaking with an attorney for a realistic assessment, rather than assuming a case exists, is the sensible step.